What were DuPont's second-quarter financial results, and how did they compare to the prior year and analyst expectations?

DuPont reported second-quarter net income of $191 million, a significant increase from $24 million in the year-ago quarter. Adjusted earnings per share (EPS) were $1.88 — 48% higher year over year and above the analysts’ consensus estimate of $1.76 per share. Net sales rose 4% year over year to $1.82 billion, with organic sales growth of 4% in healthcare and water technologies and 3% in diversified industrials.

How did DuPont's healthcare and water technologies segment perform in the second quarter, and what drove its growth?

The healthcare and water technologies segment’s operating EBITDA increased 4% year over year to $258 million on sales up 5% to $856 million; healthcare technologies sales grew by mid-single digits, led by personal protection and biopharma, while water technologies sales rose by low-single digits, supported by strength in industrial water and semiconductor markets despite weakness in the Middle East.

DuPont Income Surges on Growth in Healthcare, Aerospace

Aug 5, 2026

DuPont reported Q2 net income of $191 million, beating estimates as healthcare and water technologies drove growth. The company raised its full-year adjusted EPS guidance to $7.24 per share amid strong demand in biopharma and aerospace markets.

chemweek

2026-04-07

DuPont Completes Aramid Business Divestiture

2026-04-27

DuPont Announces 2035 Sustainability Goals

2026-05-05

DuPont lifts forecast as price hikes offset Iran war-driven costs

2026-05-06

DuPont Beats Estimates, Lifts Guidance on Price Hikes

2026-06-12

DuPont buys renewable energy certificates to cover healthcare division